BC
ATRS

Broadfin Capital’s Antares Pharma, Inc. ATRS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,336,700
Closed -$4.47M 48
2019
Q3
$4.47M Sell
1,336,700
-407,447
-23% -$1.36M 0.83% 28
2019
Q2
$5.74M Sell
1,744,147
-899,800
-34% -$2.96M 1.25% 24
2019
Q1
$8.01M Sell
2,643,947
-800,200
-23% -$2.42M 1.65% 23
2018
Q4
$9.37M Sell
3,444,147
-1,179,100
-26% -$3.21M 1.23% 20
2018
Q3
$15.5M Hold
4,623,247
2.29% 12
2018
Q2
$11.9M Sell
4,623,247
-50,000
-1% -$129K 1.88% 19
2018
Q1
$10.3M Buy
4,673,247
+137,600
+3% +$303K 1.6% 21
2017
Q4
$9.03M Buy
4,535,647
+1,329,747
+41% +$2.65M 1.48% 21
2017
Q3
$10.4M Sell
3,205,900
-1,597,628
-33% -$5.18M 1.54% 18
2017
Q2
$15.5M Sell
4,803,528
-2,838,678
-37% -$9.14M 1.88% 16
2017
Q1
$21.7M Sell
7,642,206
-5,328,887
-41% -$15.1M 2.63% 9
2016
Q4
$30.2M Sell
12,971,093
-1,914,300
-13% -$4.46M 3.36% 6
2016
Q3
$25M Hold
14,885,393
2.24% 11
2016
Q2
$15.6M Sell
14,885,393
-200,000
-1% -$210K 1.52% 18
2016
Q1
$13.1M Buy
15,085,393
+3,610,393
+31% +$3.14M 1.27% 20
2015
Q4
$13.9M Buy
11,475,000
+3,000,000
+35% +$3.63M 0.85% 29
2015
Q3
$14.4M Buy
8,475,000
+900,000
+12% +$1.53M 0.8% 29
2015
Q2
$15.8M Buy
7,575,000
+2,875,000
+61% +$5.98M 0.85% 31
2015
Q1
$12.7M Hold
4,700,000
0.99% 25
2014
Q4
$12.1M Buy
4,700,000
+1,000,000
+27% +$2.57M 1.05% 26
2014
Q3
$6.77M Buy
3,700,000
+650,000
+21% +$1.19M 0.71% 41
2014
Q2
$8.14M Buy
3,050,000
+750,000
+33% +$2M 0.79% 41
2014
Q1
$8.05M Buy
2,300,000
+1,500,000
+188% +$5.25M 0.78% 41
2013
Q4
$3.58M Buy
+800,000
New +$3.58M 0.47% 45